Purpose The purpose of this study was to evaluate the cancer care cost during the last year of life of patients in Korea. Materials and Methods We studied the breakdown of spending on the components of cancer care. Cancer decedents in 2009 were identified from the Korean Central Cancer Registry and linked with the Korean National Health Insurance Claims Database. The final number of patients included in the study was 70,558.
Results In 2009, the average cancer care cost during the last year of life was US $15,720. Patients under age 20 spent US $53,890 while those 70 or over spent US $11,801. Those with leukemia incurred the highest costs (US $43,219) while bladder cancer patients spent the least (US $13,155). General costs, drugs other than analgesics, and test fees were relatively high (29.7%, 23.8%, and 20.7% of total medical costs, respectively). Analgesic drugs, rehabilitation, and psychotherapy were still relatively low (4.3%, 0.7%, and 0.1%, respectively). Among the results of multiple regression analysis, few were notable. Age was found to be negatively related to cancer care costs while income level was positively associated. Those classified under distant Surveillance, Epidemiology, and End Results stages of cancer and higher comorbidity level also incurred higher cancer care costs. Conclusion Average cancer care costs varied significantly by patient characteristics. However, the study results suggest an underutilization of support services likely due to lack of alternative accommodations for terminal cancer patients. Further examination of utilization patterns of healthcare resources will help provide tailored evidence for policymakers in efforts to reduce the burdens of cancer care.
Citations
Citations to this article as recorded by
Patterns of Medical Utilization in Children, Adolescents, and Young Adults With Life-Limiting Conditions in Korea: A Cohort Study Based on National Health Insurance Data Seonhwa Lee, Byungmi Kim, Jin Young Choi, So-Jung Park, Jun Ah Lee, Chung Ho Kim, Bomi Park, Bohyun Park Journal of Korean Medical Science.2025;[Epub] CrossRef
Medical care costs at the end of life among older adults with cancer: a national health insurance data-based cohort study Minjeong Jo, Yunji Lee, Taehwa Kim BMC Palliative Care.2023;[Epub] CrossRef
Medical cost of advanced illnesses in the last-year of life—retrospective database study Palvinder Kaur, Huei Yaw Wu, Allyn Hum, Bee Hoon Heng, Woan Shin Tan Age and Ageing.2022;[Epub] CrossRef
Projecting Lifetime Health Outcomes and Costs Associated with the Ambient Fine Particulate Matter Exposure among Adult Women in Korea Gyeyoung Choi, Yujeong Kim, Gyeongseon Shin, SeungJin Bae International Journal of Environmental Research and Public Health.2022; 19(5): 2494. CrossRef
Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care Kyu-Tae Han, Woorim Kim, Seungju Kim BMC Cancer.2022;[Epub] CrossRef
Healthcare resource utilization and medical costs in patients with terminal cancer during best supportive care Dong-Won Kang, Yoon-Bo Shim, Eui-Kyung Lee, Mi-Hai Park, Wen-Chi Chou PLOS ONE.2022; 17(6): e0269565. CrossRef
Trends in End-of-Life Resource Utilization and Costs among Prostate Cancer Patients from 2006 to 2015: A Nationwide Population-Based Study Yun-Sok Ha, So-Young Kim, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Ji Youl Lee, Dong Jin Park, Hyun Tae Kim, Eun Sang Yoo, Tae Gyun Kwon, Kyungchan Min, Wun-Jae Kim, Seok Joong Yun, Jo The World Journal of Men's Health.2021; 39(1): 158. CrossRef
End-of-life cost trajectories and the trade-off between treatment costs and life-extension: Findings from the Cost and Medical Care of Patients with Advanced Serious Illness (COMPASS) cohort study Brett Doble, Wei Han Melvin Wong, Eric Finkelstein Palliative Medicine.2021; 35(5): 893. CrossRef
Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study Audrey Tanguy-Melac, Dorian Verboux, Laurence Pestel, Anne Fagot-Campagna, Philippe Tuppin, Christelle Gastaldi-Ménager The European Journal of Health Economics.2021; 22(7): 1039. CrossRef
How the resource allocation and inpatient behavior affect the expenditures of terminal malignant tumor patients? Fen Li, Bifan Zhu, Peimin Sang, Chunlin Jin Journal of Cancer Policy.2020; 25: 100249. CrossRef
Cost of Care and Pattern of Medical Care Use in the Last Year of Life among Long-Term Care Insurance Beneficiaries in South Korea: Using National Claims Data Sunjoo Boo, Jungah Lee, Hyunjin Oh International Journal of Environmental Research and Public Health.2020; 17(23): 9078. CrossRef
The Last Year Before Graft Failure Negatively Impacts Economic Outcomes and is Associated With Greater Healthcare Resource Utilization Compared With Previous Years in the United Kingdom: Results of a Retrospective Observational Study Gorden Muduma, Varuna Aluvihare, Marc Clancy, Enrico de Nigris, Carolyn Whitlock, Margarita Landeira, Jameel Nazir Transplantation Direct.2019; 5(5): e443. CrossRef
National practice patterns and direct medical costs for prostate cancer in Korea across a 10 year period: a nationwide population-based study using a national health insurance database Ho Won Kang, Seok-Joong Yun, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, Yun-Sok Ha, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Wun-Jae Kim, Jong-Hyock Park, Ji Youl Lee, So-Young Kim BMC Health Services Research.2019;[Epub] CrossRef
Budget impact analysis of gene expression tests to aid therapy decisions for breast cancer patients in Germany M.P. Lux, N. Nabieva, T. Hildebrandt, H. Rebscher, S. Kümmel, J.-U. Blohmer, M.G. Schrauder The Breast.2018; 37: 89. CrossRef
Intensity of Care at the End of Life Among Older Adults in Korea Su Hyun Kim, Sangwook Kang, Mi-Kyung Song Journal of Palliative Care.2018; 33(1): 47. CrossRef
Gasto en el último año de vida para pacientes que mueren con cáncer Sergio I. Prada, Juan F. Contreras Revista Colombiana de Cancerología.2018; 22(1): 3. CrossRef
Medical care costs of cancer in the last year of life using national health insurance data in Korea Mihai Park, Inmyung Song, M Barton Laws PLOS ONE.2018; 13(6): e0197891. CrossRef
The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer Shin Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo Cancer Research and Treatment.2018; 50(3): 720. CrossRef
Evaluation of the Cost of Comprehensive Outpatient Therapies in Patients with Malignant Brain Tumors Stacy McCarty, Susan Keeshin, Sarah M. Eickmeyer, Samman Shahpar, Patrick Semik, Alex W. K. Wong American Journal of Physical Medicine & Rehabilitation.2017; 96(5): 341. CrossRef
Health care services utilization during the last 6 months of life among patients with bladder cancer who underwent radical cystectomy in Quebec, Canada Ahmed S. Zakaria, Fabiano Santos, Alice Dragomir, Wassim Kassouf, Simon Tanguay, Armen Aprikian Urologic Oncology: Seminars and Original Investigations.2017; 35(9): 539.e1. CrossRef
Joint Symposium of Korean Cancer Association & UICC-ARO—Cross-boundary cancer studies: cancer and Universal Health Coverage (UHC) in Asia Eun-Cheol Park, Norie Kawahara, Shinjiro Nozaki, Hasbullah Thabrany, Shunya Yoshimi, Sohee Park, Duk Hyoung Lee, Hideyuki Akaza, Jae Kyung Roh Japanese Journal of Clinical Oncology.2017; 47(9): 889. CrossRef
Escalating Health Care Expenditures in Cancer Decedents’ Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan Yen-Ni Hung, Tsang-Wu Liu, Fur-Hsing Wen, Wen-Chi Chou, Siew Tzuh Tang The Oncologist.2017; 22(4): 460. CrossRef